Please Subscribe to get a daily link to Pat's blog via email

Subscribe!

Your privacy is important to us. We will never spam you and keep your personal data secure.

Was Controversy About Secondary Cancer Risk Among Long Term Revlimid Users Reactionary Or Overblown?

Home/Uncategorized/Was Controversy About Secondary Cancer Risk Among Long Term Revlimid Users Reactionary Or Overblown?

Was Controversy About Secondary Cancer Risk Among Long Term Revlimid Users Reactionary Or Overblown?

A fellow multiple myeloma patient blogger and good friend, Nick van Dyk, shared his views about the recent secondary cancer scare for long term users of Revlimid today: 
Some thoughts on this Revlimid situation…perhaps a false alarm?

Nick lives in California, yet he travels all of the way to Arkansas to see myeloma specialists at UAMS.  Nick is a Total Therapy patient hoping the aggressive treatment he is undergoing results in a cure. 
 
Nick brings a completely different patient perspective from mine, which is why I feature a link to his blog among my list of helpful myeloma resources, located on the right side of my homepage.

Nick is very passionate about his therapy path.  I wrote a bit about his journey in my recently updated edition of Living with Multiple Myeloma.  I kid Nick about how my very conservative “treat myeloma slowly, a little bit at a time” and his aggressive “hit the myeloma hard up front, with everything they’ve got” approaches will lead us to the same place in the end–alive and well and smiling after ten years!
 
Keep living, working and writing, Nick!  Maybe you should start writing that book about Total Therapy and your experiences at UAMS you told me about last spring…
 
Feel good and keep smiling!  Pat